• Eleven Biotherapeutics Announces Top-Lin...
    From Eleven Biotherapeutics
    Eleven Biotherapeutics announced top-line results from a phase 2 study of its lead drug candidate, EBI-005, in patients with moderate to severe allergic conjunctivitis. T... (Read more)
  • Protein Content in Compounded Bevacizuma...
    From Medscape Ophthalmology
    The protein concentration of bevacizumab prepared by U.S. compounding pharmacies for intravitreal injection shows significant variations, according to New York-based rese... (Read more)
  • Italian Research Provides Preliminary Ev...
    From Medical News Today
    The poster presented during the EuCornea Congress describes the preliminary results of the Phase I segment of the REPARO Study, a randomized, double-masked, placebo contr... (Read more)
  • Johnson & Johnson Vision Care Announces ...
    From Johnson & Johnson Vision Care
    Johnson & Johnson Vision Care announced that Acuvue Oasys brand contact lenses for astigmatism is now the first and only silicone hydrogel toric contact lens with -2.... (Read more)
  • Marco Expands its Management Team
    From Marco
    Marco, a provider of diagnostic equipment for the eye care market, has announced it is expanding its management team. Below are descriptions of new management positions w... (Read more)

Subscribe to


Mission Statement

New Retina MD is a publication that delivers the latest information on clinical and non-clinical issues that are pertinent to retina specialists in their first 5 to 15 years of practice. Areas of focus include surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, and financial planning. Each issue provides insight from well-respected voices in appropriate fields of expertise and is designed to fit the needs of physicians in the earlier stages of their careers.